Inhibition of nitric oxide synthesis in ischemia/reperfusion of the rat liver is followed by impairment of hepatic microvascular blood flow

J Hepatol. 1997 Jul;27(1):163-9. doi: 10.1016/s0168-8278(97)80297-8.

Abstract

Background: Recent studies provide evidence that nitric oxide (NO) has beneficial effects in hepatic ischemia/reperfusion injury. The purpose of this study was to evaluate whether nitric oxide is involved in the regulation of hepatic microvascular perfusion after warm hepatic ischemia. Therefore, we performed a study using in vivo fluorescence microscopy.

Methods: Clamping of the left liver lobe was performed in male Wistar rats for the duration of 70 min. One experimental group (n=8) received L-NAME (Nw-nitro-L-arginine methyl ester hydrochloride), an NO-synthase inhibitor, 1 min prior to reperfusion. A second experimental group (n=8) received L-arginine (NO-substrate) continuously infused throughout the observation period. Controls (n=8) received equivalent volumes of an isotonic solution and underwent the same procedures. Hepatic microvascular blood flow and leukocyte-endothelial cell interaction was studied between 20 and 90 min after reperfusion using in vivo fluorescence microscopy.

Results: Inhibition of NO-synthesis during reperfusion by application of L-NAME caused a marked decrease in sinusoidal blood flow velocity. Furthermore, we noted an increase of non-perfused sinusoids in this group. Treatment with L-arginine improved functional perfusion of hepatic acini and reduced significantly the number of adherent leukocytes in sinusoids and venules compared to control animals.

Conclusions: Our results provide further evidence that NO maintains postischemic hepatic microvascular perfusion and that inhibition of NO synthesis has detrimental effects on hepatic microhemodynamics during reperfusion.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arginine / pharmacology
  • Blood Flow Velocity / drug effects
  • Cell Adhesion / drug effects
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / physiology
  • Enzyme Inhibitors / pharmacology
  • Leukocytes / drug effects
  • Leukocytes / physiology
  • Liver / blood supply*
  • Liver / drug effects
  • Liver / physiopathology
  • Male
  • Microcirculation / drug effects
  • NG-Nitroarginine Methyl Ester / pharmacology
  • Nitric Oxide / antagonists & inhibitors*
  • Rats
  • Rats, Wistar
  • Reperfusion Injury / physiopathology*

Substances

  • Enzyme Inhibitors
  • Nitric Oxide
  • Arginine
  • NG-Nitroarginine Methyl Ester